Correlation Between Meitav Dash and Lineage Cell

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Meitav Dash and Lineage Cell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Meitav Dash and Lineage Cell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Meitav Dash Investments and Lineage Cell Therapeutics,, you can compare the effects of market volatilities on Meitav Dash and Lineage Cell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Meitav Dash with a short position of Lineage Cell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Meitav Dash and Lineage Cell.

Diversification Opportunities for Meitav Dash and Lineage Cell

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Meitav and Lineage is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Meitav Dash Investments and Lineage Cell Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lineage Cell Therape and Meitav Dash is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Meitav Dash Investments are associated (or correlated) with Lineage Cell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lineage Cell Therape has no effect on the direction of Meitav Dash i.e., Meitav Dash and Lineage Cell go up and down completely randomly.

Pair Corralation between Meitav Dash and Lineage Cell

Assuming the 90 days trading horizon Meitav Dash is expected to generate 37.69 times less return on investment than Lineage Cell. But when comparing it to its historical volatility, Meitav Dash Investments is 137.41 times less risky than Lineage Cell. It trades about 0.76 of its potential returns per unit of risk. Lineage Cell Therapeutics, is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest  32,200  in Lineage Cell Therapeutics, on August 27, 2024 and sell it today you would lose (12,620) from holding Lineage Cell Therapeutics, or give up 39.19% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Meitav Dash Investments  vs.  Lineage Cell Therapeutics,

 Performance 
       Timeline  
Meitav Dash Investments 

Risk-Adjusted Performance

28 of 100

 
Weak
 
Strong
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Meitav Dash Investments are ranked lower than 28 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Meitav Dash sustained solid returns over the last few months and may actually be approaching a breakup point.
Lineage Cell Therape 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Lineage Cell Therapeutics, are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Lineage Cell sustained solid returns over the last few months and may actually be approaching a breakup point.

Meitav Dash and Lineage Cell Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Meitav Dash and Lineage Cell

The main advantage of trading using opposite Meitav Dash and Lineage Cell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Meitav Dash position performs unexpectedly, Lineage Cell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lineage Cell will offset losses from the drop in Lineage Cell's long position.
The idea behind Meitav Dash Investments and Lineage Cell Therapeutics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance